Home > Insider Trading > Filing (0001574774-19-000006)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1574774	Biotelemetry Inc.	BEAT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1481485	C Heather Getz	1000 Cedar Hollow Rd. Suite 102 Malvern PA 19355	Executive Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-01-31	100	$2.80	80,661	No	4	M	Direct
Common Stock	Disposition	2019-01-31	100	$70.01	80,561	No	4	S	Direct
Common Stock	Acquisiton	2019-02-01	10,490	$2.80	91,051	No	4	M	Direct
Common Stock	Disposition	2019-02-01	10,490	$70.41	80,561	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2019-01-31	100	$0.00	100	$2.80
Common Stock	Stock Options (Right to Buy)	Disposition	2019-02-01	10,490	$0.00	10,490	$2.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,490		2022-02-21	No	4	M	Direct
0		2022-02-21	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $72.12, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015.